Author:
Andrei Adin-Cristian,Grady Kathleen L.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference24 articles.
1. Spilker, B. (1996). Quality of life and pharmacoeconomics in clinical trials (2nd ed.). New York: Lippincott Williams & Williams.
2. Ware, J. E., Kosinski, M., Dewey, J. E., & Gandek, B. (2000) . SF-36 health survey: Manual and interpretation guide. Quality Metric Inc. Boston: Health Institute, New England Medical Center, 1993.
3. Parasuraman, S., Hudes, G., Levy, D., Strahs, A., Moore, L., DeMarinis, R., et al. (2007). Comparison of quality-adjusted survival in patients with advanced renal cell carcinoma receiving first-line treatment with temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of IFN+TEMSR. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 25(18S), 5049.
4. Kaarlola, A., Tallgren, M., & Pettil, V. (2006). Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients. Critical Care Medicine, 34(8), 2120–2126.
5. Muennig, P. A., & Gold, M. R. (2001). Using the years-of-healthy-life measure to calculate QALYs. American Journal of Preventive Medicine, 20(1), 35–39.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献